Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yasuo Nakagishi
Observed names:
Y. Nakagishi,
YASUO NAKAGISHI,
Yasuo NAKAGISHI
Institution:
Kobe Children's Hospital
Observed institutions:
Kanazawa University,
Albert Einstein College of Medicine,
Tel Aviv University,
Kyoto University,
Schneider Children's Medical Center,
Kobe Children's Hospital,
Asklepios Klinik Sankt Augustin,
Asklepios,
Yokohama City University
show all 9
ORCID:
0009-0003-8956-2244
Observed ORCID:
0009-0003-8956-2244
OpenAlex ID:
A5040109141
Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis
2015
·
Masaki Shimizu
, Yasuo Nakagishi
, et al.
·
Clinical Immunology
·
180
Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The diagnostic significance of interleukin-18 and interleukin-6
2012
·
Masaki Shimizu
, Yasuo Nakagishi
, et al.
·
Cytokine
·
131
Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles
2012
·
Masaki Shimizu
, Yasuo Nakagishi
, et al.
·
Cytokine
·
128
Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome
2019
·
Mao Mizuta
, Masaki Shimizu
, et al.
·
Cytokine
·
56
Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
2020
·
Masaki Shimizu
, Mao Mizuta
, et al.
·
Pediatric Rheumatology
·
50
PDF
Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease
2016
·
Mao Mizuta
, Masaki Shimizu
, et al.
·
Modern Rheumatology
·
45
Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis
2018
·
Naoto Sakumura
, Masaki Shimizu
, et al.
·
Cytokine
·
44
Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)
2019
·
Junko Yasumura
, Masato Yashiro
, et al.
·
Pediatric Rheumatology
·
41
PDF
Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease
2014
·
Tadamori Takahara
, Masaki Shimizu
, et al.
·
Rheumatology International
·
41
Clinical significance of interleukin-18 for the diagnosis and prediction of disease course in systemic juvenile idiopathic arthritis
2020
·
Mao Mizuta
, Masaki Shimizu
, et al.
·
Rheumatology
·
40
Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children
2020
·
Mao Mizuta
, Masaki Shimizu
, et al.
·
Rheumatology
·
40
Improving survival in patients with trisomy 18
2021
·
Shoko Tamaki
, Sota Iwatani
, et al.
·
American Journal of Medical Genetics Part A
·
34
Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
2019
·
Maiko Takakura
, Masaki Shimizu
, et al.
·
Clinical Immunology
·
30
Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience
2022
·
Takayuki Miyamoto
, Yoshitaka Honda
, et al.
·
Frontiers in Immunology
·
29
Successful therapy of macrophage activation syndrome with dexamethasone palmitate
2014
·
Yasuo Nakagishi
, Masaki Shimizu
, et al.
·
Modern Rheumatology
·
25
Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus
2019
·
Masaaki Usami
, Masaki Shimizu
, et al.
·
Clinical Immunology
·
23
Serum Leucine-Richα2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis
2019
·
Masaki Shimizu
, Natsumi Inoue
, et al.
·
Journal of Immunology Research
·
22
PDF
Validation of Classification Criteria of Macrophage Activation Syndrome in Japanese Patients With Systemic Juvenile Idiopathic Arthritis
2017
·
Masaki Shimizu
, Mao Mizuta
, et al.
·
Arthritis Care & Research
·
22
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
2017
·
F. De Benedetti
, PRINTO/PRCSG
, et al.
·
Pediatric Rheumatology
·
21
PDF
Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers
2023
·
Shuya Kaneko
, Masaki Shimizu
, et al.
·
Cytokine
·
18
Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series
2017
·
Masaki Shimizu
, Yasuo Nakagishi
, et al.
·
Modern Rheumatology
·
17
Clinical Characteristics of Cryopyrin‐Associated Periodic Syndrome and Long‐Term Real‐World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey
2024
·
Takayuki Miyamoto
, Kazushi Izawa
, et al.
·
Arthritis & Rheumatology
·
16
PDF
Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
2019
·
Ryoki Hara
, Hiroaki Umebayashi
, et al.
·
Pediatric Rheumatology
·
16
PDF
Serum Cytokine Profiling Differentiates Underlying Diseases in Cytokine Storm Syndrome
2025
·
Shuya Kaneko
, Maho Hatano
, et al.
·
Arthritis & Rheumatology
·
15
Epidemiology conduction of paediatric rheumatic diseases based on the registry database of the Pediatric Rheumatology Association of Japan
2022
·
Hidehiko Narazaki
, Shinji Akioka
, et al.
·
Modern Rheumatology
·
14
Show more works
View as search
Works count:
76
Citation count:
1,257
H-index:
19
I10-index:
28
Year
Topic
Type
